Ainos, Inc. Enters Material Definitive Agreement
Ticker: AIMDW · Form: 8-K · Filed: Oct 17, 2025 · CIK: 1014763
Sentiment: neutral
Topics: material-agreement, corporate-action
Related Tickers: AIMD
TL;DR
Ainos, Inc. signed a big deal on Oct 15th, filing today.
AI Summary
On October 15, 2025, Ainos, Inc. entered into a material definitive agreement. The company, formerly known as Amarillo Biosciences Inc., is incorporated in Texas and its fiscal year ends on December 31st. The filing was made on October 17, 2025.
Why It Matters
This filing indicates a significant new development or contract for Ainos, Inc., which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities, the specifics of which are not detailed in this initial filing.
Key Numbers
- 001-41461 — SEC File Number (Identifies the company's filing history with the SEC.)
- 75-1974352 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Ainos, Inc. (company) — Registrant
- October 15, 2025 (date) — Date of earliest event reported
- October 17, 2025 (date) — Filing date
- Amarillo Biosciences Inc. (company) — Former company name
- Texas (jurisdiction) — State of incorporation
FAQ
What is the nature of the material definitive agreement entered into by Ainos, Inc. on October 15, 2025?
The filing does not specify the details of the material definitive agreement, only that one was entered into on October 15, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on October 17, 2025.
What was Ainos, Inc. formerly known as?
Ainos, Inc. was formerly known as Amarillo Biosciences Inc.
In which state is Ainos, Inc. incorporated?
Ainos, Inc. is incorporated in Texas.
What is the fiscal year end for Ainos, Inc.?
The fiscal year end for Ainos, Inc. is December 31st.
Filing Stats: 642 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2025-10-17 16:10:56
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share AIMD The Nasdaq Stock Mar
- $50,000 — fee for the exclusive use of patents of $50,000 per month (plus 5% sales tax) for a two
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex10-1.htm (EX-10.1) — 2KB
- ex10-1_001.jpg (GRAPHIC) — 410KB
- ex10-1_002.jpg (GRAPHIC) — 69KB
- 0001493152-25-018460.txt ( ) — 907KB
- aimd-20251015.xsd (EX-101.SCH) — 4KB
- aimd-20251015_def.xml (EX-101.DEF) — 26KB
- aimd-20251015_lab.xml (EX-101.LAB) — 36KB
- aimd-20251015_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Ainos, Inc. Date: October 17, 2025 By: /s/ Chun-Hsien Tsai Name: Chun-Hsien Tsai Title: Chief Executive Officer